Your browser doesn't support javascript.
loading
The EUTOS long-term survival (ELTS) score is superior to the Sokal score for predicting survival in chronic myeloid leukemia.
Pfirrmann, Markus; Clark, Richard E; Prejzner, Witold; Lauseker, Michael; Baccarani, Michele; Saussele, Susanne; Guilhot, François; Heibl, Sonja; Hehlmann, Rüdiger; Faber, Edgar; Turkina, Anna; Ossenkoppele, Gert; Höglund, Martin; Zaritskey, Andrey; Griskevicius, Laimonas; Olsson-Strömberg, Ulla; Everaus, Hele; Koskenvesa, Perttu; Labar, Boris; Sacha, Tomasz; Zackova, Daniela; Cervantes, Francisco; Colita, Adriana; Zupan, Irena; Bogdanovic, Andrija; Castagnetti, Fausto; Guilhot, Joëlle; Hasford, Joerg; Hochhaus, Andreas; Hoffmann, Verena S.
Afiliação
  • Pfirrmann M; Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie - IBE, Ludwig-Maximilians Universität, Munich, Germany. pfi@ibe.med.uni-muenchen.de.
  • Clark RE; Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK.
  • Prejzner W; Medical University of Gdansk, Gdansk, Poland.
  • Lauseker M; Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie - IBE, Ludwig-Maximilians Universität, Munich, Germany.
  • Baccarani M; Clinical Department of Hematology and Oncology L. and A. Seragnoli, S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.
  • Saussele S; III. Medizinische Klinik, Universitätsmedizin Mannheim, Medizinische Fakultät Mannheim der Universität Heidelberg, Mannheim, Germany.
  • Guilhot F; Clinical Investigation Centre, INSERM CIC 1402, CHU Poitiers, Poitiers, France.
  • Heibl S; Abteilung für Innere Medizin IV, Klinikum Wels-Grieskirchen, Wels, Austria.
  • Hehlmann R; III. Medizinische Klinik, Universitätsmedizin Mannheim, Medizinische Fakultät Mannheim der Universität Heidelberg, Mannheim, Germany.
  • Faber E; ELN Foundation, Weinheim, Germany.
  • Turkina A; Department of Hemato-Oncology, Faculty Hospital Olomouc, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic.
  • Ossenkoppele G; National Research Center for Hematology, Ministry of Healthcare of the Russian Federation, Moscow, Russian Federation.
  • Höglund M; Department of Hematology, VU University Medical Center, Amsterdam, Netherlands.
  • Zaritskey A; Institution of Medical Sciences, University of Uppsala, Uppsala, Sweden.
  • Griskevicius L; Almazov Medical Reseach Centre, Institute of Oncology and Hematology, St Petersburg, Russian Federation.
  • Olsson-Strömberg U; Institute of Clinical Medicine, Vilnius University, Vilnius, Lithuania.
  • Everaus H; Department of Medical Sciences, University of Uppsala and Section of Hematology, Uppsala University Hospital, Uppsala, Sweden.
  • Koskenvesa P; Tartu University Hospital, Tartu, Estonia.
  • Labar B; Hematology Research Unit Helsinki, University of Helsinki and Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
  • Sacha T; School of Medicine, University of Zagreb, Zagreb, Croatia.
  • Zackova D; Department of Hematology, Jagiellonian Unversity Medical College, Kraków, Poland.
  • Cervantes F; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic.
  • Colita A; Hematology Department, Hospital Clinic, IDIBAPS, Barcelona, Spain.
  • Zupan I; Romanian Academy of Medical Sciences and Medical University, Bucharest, Romania.
  • Bogdanovic A; Department of Hematology, University Medical Centre, Ljubljana, Slovenia.
  • Castagnetti F; Clinic of Hematology, Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
  • Guilhot J; Clinical Department of Hematology and Oncology L. and A. Seragnoli, S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.
  • Hasford J; Clinical Investigation Centre, INSERM CIC 1402, CHU Poitiers, Poitiers, France.
  • Hochhaus A; Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie - IBE, Ludwig-Maximilians Universität, Munich, Germany.
  • Hoffmann VS; Klinik für Innere Medizin II, Universitätsklinikum Jena, Jena, Germany.
Leukemia ; 34(8): 2138-2149, 2020 08.
Article em En | MEDLINE | ID: mdl-32601376
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Ano de publicação: 2020 Tipo de documento: Article